Sanofi (SNY) Tops Q1 EPS by 16c

Sanofi (NASDAQ: SNY) reported Q1 EPS of EUR2.16, EUR0.16 better than the analyst estimate of EUR2.00. Revenue for the quarter came in at EUR10.22 billion versus the consensus estimate of EUR10.3 billion.

Confirms FY23 guidance of business EPS growing low single digit at constant exchange rates

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight